Home › Funds › Patient Square Capital LP › IVA

Patient Square Capital LP position in IVA

INVENTIVA SA · Health Care

Patient Square Capital LP reported holding 1,221,225 shares of IVA (INVENTIVA SA) in its Q3 2026 13F filing — a position valued at US$4.5M, representing 0.72% of its reported portfolio and ranking #22 among its reported holdings. Patient Square Capital LP has disclosed IVA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.22M sh
Reported value held$4.51M
Portfolio Weight0.72%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's IVA position evolved

Patient Square Capital LP first disclosed a stake in IVA in Q2 2026 at 1,967,171 shares (US$7.4M). Across 2 filings, Patient Square Capital LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,221,225 shares valued at US$4.5M — a reduction of -745,946 shares quarter over quarter.. Notable position changes include a 38% trim in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.97M $7.44M New
Q3 2026 1.22M $4.51M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IVA and 13F data

IVA (INVENTIVA SA) is a Health Care company. 88 other funds we track also report a position in IVA — the largest reported positions include Caligan Partners LP (US$30.9M), Samsara BioCapital, LLC (US$23.9M), Paradigm Biocapital Advisors LP (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IVA

All IVA fund holders →

FAQ

How long has Patient Square Capital LP held IVA?

Patient Square Capital LP has disclosed IVA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Patient Square Capital LP's current position in IVA?

As of Q3 2026, Patient Square Capital LP holds 1.22M shares of IVA (INVENTIVA SA), valued at $4.51M, representing 0.72% of its reported portfolio and ranking #22.

Has Patient Square Capital LP been buying or selling IVA?

In the latest 13F filing (Q3 2026), Patient Square Capital LP reduced its position in IVA.

Which other funds hold IVA?

Other major institutional holders of IVA include Caligan Partners LP, Samsara BioCapital, LLC, Paradigm Biocapital Advisors LP, among 88 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.